GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » Cyclically Adjusted FCF per Share

Whanin Pharm Co (XKRX:016580) Cyclically Adjusted FCF per Share : ₩420.71 (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Whanin Pharm Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ₩-483.967. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩420.71 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Whanin Pharm Co's average Cyclically Adjusted FCF Growth Rate was -15.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -20.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -11.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Whanin Pharm Co was 6.50% per year. The lowest was -20.00% per year. And the median was 3.40% per year.

As of today (2024-06-19), Whanin Pharm Co's current stock price is ₩14200.00. Whanin Pharm Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ₩420.71. Whanin Pharm Co's Cyclically Adjusted Price-to-FCF of today is 33.75.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Whanin Pharm Co was 38.15. The lowest was 13.90. And the median was 24.97.


Whanin Pharm Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Whanin Pharm Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co Cyclically Adjusted FCF per Share Chart

Whanin Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 801.94 800.27 943.55 522.64 409.80

Whanin Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 494.74 487.86 425.76 409.80 420.71

Competitive Comparison of Whanin Pharm Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Whanin Pharm Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Whanin Pharm Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Whanin Pharm Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Whanin Pharm Co's Cyclically Adjusted Price-to-FCF falls into.



Whanin Pharm Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Whanin Pharm Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-483.967/118.8477*118.8477
=-483.967

Current CPI (Mar. 2024) = 118.8477.

Whanin Pharm Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 154.428 99.353 184.729
201409 311.056 99.608 371.138
201412 126.708 99.098 151.960
201503 188.539 99.720 224.703
201506 178.537 100.050 212.081
201509 127.810 100.110 151.732
201512 328.547 100.220 389.613
201603 344.393 100.560 407.024
201606 124.997 100.790 147.392
201609 35.750 101.460 41.877
201612 303.965 101.560 355.706
201703 304.487 102.850 351.848
201706 18.945 102.610 21.943
201709 -336.084 103.490 -385.958
201712 285.264 102.990 329.187
201803 247.773 104.100 282.875
201806 13.128 104.130 14.984
201809 401.864 105.650 452.064
201812 179.489 104.350 204.426
201903 531.384 104.490 604.400
201906 -269.494 104.880 -305.385
201909 597.620 105.200 675.150
201912 562.588 105.120 636.057
202003 515.078 105.540 580.025
202006 126.574 104.870 143.445
202009 484.155 106.200 541.815
202012 -174.312 105.765 -195.873
202103 448.297 107.357 496.278
202106 336.957 107.579 372.254
202109 516.229 108.759 564.114
202112 699.600 109.676 758.102
202203 -3,199.342 111.806 -3,400.847
202206 -546.716 114.083 -569.551
202209 417.589 114.831 432.195
202212 -3.233 115.200 -3.335
202303 -105.353 116.550 -107.430
202306 -196.863 117.140 -199.733
202309 -459.471 119.111 -458.455
202312 218.502 118.848 218.502
202403 -483.967 118.848 -483.967

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Whanin Pharm Co  (XKRX:016580) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Whanin Pharm Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=14200.00/420.71
=33.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Whanin Pharm Co was 38.15. The lowest was 13.90. And the median was 24.97.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Whanin Pharm Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Whanin Pharm Co (XKRX:016580) Business Description

Traded in Other Exchanges
N/A
Address
84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200
Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co (XKRX:016580) Headlines

No Headlines